Antibody-induced apoptosis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 21, 1998
Grant Date -
N/A
app pub date -
Dec 5, 1995
filing date -
Dec 5, 1995
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells are disclosed. The antibodies are used to 'tag' Her2 overexpressing tumors for elimination by the host immune system. Also disclosed are hybridoma cell lines producing the antibodies, methods for treating cancer using the antibodies, and pharmaceutical compositions.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully